A client is in the initial treatment phase for tuberculosis.
Which of the following antitubercular drugs would the nurse expect the client to receive during this phase?

Choice A rationale:

Administering a combination of drugs in TB treatment is not primarily aimed at preventing the incidence of liver dysfunction. The combination therapy's main objective is to address the complex nature of Mycobacterium tuberculosis infections and the potential development of antibiotic resistance.

Choice B rationale:

The nurse should explain that the primary reason for administering a combination of drugs is to slow down bacterial resistance. When TB is treated with a single drug, the bacteria can quickly develop resistance to that drug. Using a combination of drugs with different mechanisms of action makes it more difficult for the bacteria to develop resistance. This is a fundamental principle in the treatment of TB.

Choice C rationale:

Slowing the body's resistance to medication is not a goal in TB treatment. The focus is on preventing the development of resistance in the bacteria, not the body's response to the medication.

Choice D rationale:

While TB treatment aims to prevent the further spread of the disease, the primary reason for using a combination of drugs is to address bacterial resistance. Preventing the spread of TB is an important secondary benefit of effective treatment.

Choice A rationale:

Fertility problems are one of the long-term adverse reactions that may occur with antineoplastic therapy. Some chemotherapy drugs can impact fertility in both males and females, either temporarily or permanently. It's important to discuss these potential effects with patients before starting treatment, as it may influence their decisions about family planning.

Choice B rationale:

Thrombocytopenia is not a long-term adverse reaction but a potential short-term side effect of antineoplastic therapy. Thrombocytopenia is a condition characterized by a low platelet count and can lead to bleeding problems.

Choice C rationale:

Leukopenia is not a long-term adverse reaction but rather a potential short-term side effect of antineoplastic therapy. Leukopenia refers to a decrease in white blood cell count and can increase the risk of infections.

Choice D rationale:

Stomatitis is not typically considered a long-term adverse reaction to antineoplastic therapy. Stomatitis is a common side effect of chemotherapy that involves inflammation of the mucous membranes in the mouth, and it usually occurs during treatment rather than persisting as a long-term effect.